Those that fail to adapt their workforce strategies will remain stuck in crisis mode, scrambling to fill shifts and struggling to retain nurses in the face of a nursing shortage. But for those willing to welcome change, the opportunity is immense. The post Healthcare’s Workforce Blueprint is Out Of Date. It’s Time For A Change…
Maryland is the first state to tap into an old fund connected to the Affordable Care Act to help solve a new problem: helping pay the expenses of patients who travel to Maryland for an abortion. With abortion now restricted or illegal in 22 states, jurisdictions like Maryland have become a destination for patients from…
The federal Consumer Financial Protection Bureau on Tuesday issued new regulations barring medical debts from American credit reports, enacting a major new consumer protection just days before President Joe Biden is set to leave office. The rules ban credit agencies from including medical debts on consumers’ credit reports and prohibit lenders from considering medical information…
Family premiums for employer-sponsored health insurance rose 7% this year to reach an average of $25,572 annually, KFF’s 2024 benchmark Employer Health Survey finds. On average, workers contribute $6,296 annually to the cost of family coverage. This marks the second year in a row that premiums are up 7%. Over the past five years—a…More
HumoTech has developed a robotic platform that lets patients quickly trial multiple prosthetic or exoskeleton options in a clinic, using both objective data and patient feedback to identify the best fit. The technology aims to reduce device abandonment and improve outcomes. The post How One Company Aims to Fix the Prosthetic Fitting Process appeared first…
KFF’s Survey of Medicaid Financial Eligibility for Older Adults & People with Disabilities, conducted in March 2025 by KFF and Watts Health Policy Consulting, provides a baseline of Medicaid eligibility as states return to normal operations after the end of the COVID-19 pandemic and ahead of potential changes to the Medicaid program.
Takeda said more than half of plaque psoriasis patients treated with zasocitinib achieved clear or almost clear skin in two Phase 3 studies. Regulatory submissions for the TYK2 inhibitor are planned for 2026 and clinical trials are ongoing in other indications. The post Takeda Drug From $4B Deal Succeeds in Two Pivotal Plaque Psoriasis Trials…
That is the question asked by a 2022 NBER working paper by Pierre Dubois, Ashvin Gandhi and Shoshana Vasserman. Methodology: Demand Side Model The authors used IQVIA data on revenues and quantities of drugs sold to hospitals from 2002 to 2013 across US, Canada, France, Germany, Italy, Spain and UK markets. The authors define a…
Akero Therapeutics reported that at 96 weeks, 39% of patients who received the 50 mg dose of efruxifermin achieved improvement in fibrosis, or liver scarring, caused by the fatty liver disease MASH. This study previously failed to achieve statistically significant improvement at 36 weeks, but Akero executives say the latest results show that longer dosing…